Clinical Trials Directory

Trials / Unknown

UnknownNCT02000349

Comparison of Frozen-thawed Embryo Transfers and Fresh Embryo Transfers With Whole Chromosome Analysis Using Next Generation Sequencing

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
186 (estimated)
Sponsor
Reprogenetics · Industry
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Not accepted

Summary

The investigators propose to perform a clinical randomized trial to evaluate the effect of a frozen-thawed embryo transfer and a fresh embryo transfer on pregnancy and implantation rates; with the added benefit of a blastocyst biopsy and whole chromosome analysis by Next Generation Sequencing (NGS).

Detailed description

1. Fresh group: All embryos will be hatched on day 3. Patients will have hatching blastocysts (\*) biopsied on day 5, analyzed by NGS, and will have one or two euploid embryo transferred on day 6, in the am. If more than two euploid blastocysts are available the one(s) to be transferred will be selected based on morphology (\*). Any morulas developing to hatching blastocyst on day-6 will be also analyzed but vitrified for use in a future cycle. 2. Frozen group: All embryos will be hatched on day 3. Patients will have hatching blastocysts (\*) biopsied on day 5 or day 6, embryos will then be vitrified, analyzed by NGS, and will have one or two euploid embryo(s) thawed and transferred on a FET cycle, before noon. If more than two euploid blastocysts are available the one(s) to be transferred will be selected based on morphology (\*). (\*) Hatching blastocysts as described by Gardner and Schoolcraft (1999):

Conditions

Interventions

TypeNameDescription
OTHERPGDPGD using Next generation sequencing

Timeline

Start date
2013-09-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2013-12-04
Last updated
2015-11-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02000349. Inclusion in this directory is not an endorsement.